- Report
- May 2024
- 138 Pages
Global
From €5831EUR$6,499USD£5,019GBP
- Report
- June 2024
- 200 Pages
Global
From €7133EUR$7,950USD£6,140GBP
- Report
- January 2022
- 60 Pages
Global
From €3544EUR$3,950USD£3,050GBP
Alstrom Syndrome is a rare genetic disorder that affects multiple organs and systems in the body, including the central nervous system. As a result, drugs used to treat Alstrom Syndrome often target the central nervous system. These drugs are typically used to manage symptoms such as vision and hearing loss, obesity, diabetes, and heart problems. Commonly prescribed drugs include diuretics, anticonvulsants, and anti-inflammatory medications. Additionally, drugs that target the central nervous system may be used to improve cognitive functioning and reduce the risk of seizures.
The Alstrom Syndrome Drug market is a specialized market that focuses on providing treatments for this rare disorder. Companies in this market are typically focused on developing and manufacturing drugs that target the central nervous system. Examples of companies in this market include AbbVie, Novartis, and Sanofi. Show Less Read more